The bm|t is pleased to announce that seven of its Investee Partners have already closed funding rounds in 2018. Over €10 million has been raised by Biano GMP, ifesca, JenID, MasterPIM, OnCGnostics, Preventicus and SiOptica. The money secures funds for important and value-adding further developments.
These investment rounds continue the momentum from 2017, which saw over €150 million invested in 21 portfolio companies. Kevin Reeder, CEO of bm|t, sees the continuation of the fundraising as a great signal for Thuringia and a strong signal to investors to show the attractiveness of investing in the region. “With two very successful and highly publicised exits last year — a sale to Facebook and a Nasdaq IPO, bm|t has appeared on the radar screens of many investors. We see a growing interest in co-investments together with bm|t here in Thuringia, which will greatly help us catalyse the next Thuringian champions.”
Of particular note, two of the 2018 financings drew several million euros from outside Germany, with one investment coming from Switzerland and another from Belgium. “We know that our companies have powerful innovations and great substance, and we are pleased that other investors outside Germany have recognised this and will work with us as co-investors to move these companies forward,” Reeder said.
About Biano GMP
BianoGMP GmbH was founded in August 2017 with the aim of establishing itself as a GMP service provider for medium to small batch sizes in the growth segment of oligonucleotides, thereby lowering the barriers for potential customers to enter preclinical and clinical development. In addition, innovative new and further developments in related services are planned in order to offer customers the broadest possible spectrum around GMP-compliant nucleotide production from a single source.
Further information on BianoGMP can be found at: bianoscience.com/GMP_Oligonucleotides.
Founded in 2016 in Ilmenau, ifesca offers decision support solutions and services based on artificial intelligence for the energy market. High-quality forecasts for energy-related time series and optimised operations for energy generation are provided by the specialised IoT platform ifesca.AIVA. ifesca’s “as a service” solutions massively help automate decision-making processes, thereby increasing forecast quality and reducing manual effort and process complexity. The services are provided to every participant in the global energy markets. Working in these markets for over 15 years and having a scientific background enables the ifesca team to develop its unparalleled AI solutions.
For more information on ifesca, please visit: www.ifesca.de ifesca-aiva.com/
jenID Solutions provides flexible software solutions for customers in financial services, insurance, car rental, telecommunications and other industries, tailored to their needs and enabling them to perform secure, real-time identity verification anywhere in the world. The company thus knows who is accessing, using or borrowing its products. The jenID thus helps protect the identity of end users and prevents fraud.
For more information on jenID Solutions, please visit: www.jenidsolutions.com
MasterPIM develops a browser-based tool for straightforward product information management (PIM). The modular structure enables the mapping of simple data conversion up to a fully scalable enterprise solution for retailers and manufacturers, without large project management, without lengthy integration processes. Master PIM deliberately avoids feature-driven onboarding processes and instead relies on pragmatic, standardised out-of-the-box solutions.
For more information on MasterPIM, please visit: http://www.masterpim.de/
oncgnostics GmbH was founded in 2012 as a spin-off from a university research group at the University Women’s Hospital in Jena. As a molecular diagnostics company, the Jena-based start-up specialises in the diagnosis of cancer. The tests detect characteristic epigenetic changes, so-called DNA methylations, in cancer cells. The biomarkers, identified and patented with a special algorithm, form the core of the products and are the basis of the company.
For more information about oncgnostics, please visit: http://www.oncgnostics.com/.
Preventicus turns a smartphone into a medical measuring tool. This makes it possible for users to carry out previously complex preventive examinations at home via smartphone and to maintain their own health through precisely tailored preventive measures. The USP of Preventicus are superior biosignal-analytical algorithms with high clinical evidence, which enable risk screening via smartphone. Individual prevention measures are derived from the health profile, their effect is monitored and users are connected with health partners.
For more information about Preventicus, please visit: http://www.preventicus.com/
The company was founded in Jena in 2013 with the aim of establishing innovative and specialised solutions in the market, especially in the field of optics. The company offers technologies in the field of privacy filters that can protect screen data from unauthorised view without causing brightness loss and can be operated in public or private modes. SiOptica’s solutions offer great benefits in the ATM / banking, retail / payment terminal, logistics / secure access, data security and consumer electronics sectors.
For more information about SiOptica, please visit: www.sioptica.com
The Erfurt-based bm‑t beteiligungsmanagement Thüringen (bm|t) — a subsidiary of the Thüringer Aufbaubank — is the first port of call for investments in Thuringia. Currently, bm|t manages eight investment funds with a total volume of € 320 million. bm|t invests in innovative companies with strong growth potential across all sectors and all phases of the company life cycle.
Further information on bm|t can be found at: www.bm‑t.com